trending Market Intelligence /marketintelligence/en/news-insights/trending/JNVqTHXTQn3j5pWqC4AagQ2 content esgSubNav
In This List

Vanc Pharmaceuticals appoints board member

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


Vanc Pharmaceuticals appoints board member

Vanc Pharmaceuticals Inc. appointed Robert Sindelar to its board of directors.

The Vancouver, British Columbia-based generic and over-the-counter medicine manufacturer said Sindelar serves as professor, faculty of pharmaceutical sciences at the University of British Columbia.

"Sindelar's background is ideally suited to helping VANC build upon the increasing importance of community pharmacy in healthcare," CEO Bob Rai said in a statement.

Sindelar added: "Current trends suggest that community pharmacy's direct role in patient care services and wellness are growing and VANC has focused on delivering proven enabling technologies to further support this trend and the attendant growth in community pharmacy business activities."